Search
for
Sort by
Research 781–810 of 1000+
- Androgen binding profiles of two distinct nuclear androgen receptors in Atlantic croaker (Micropogonias undulatus)
- ACNE
- The Evaluation of the Role of Androgens in Hirsutism and the Use of a New Anti-androgen “Cyproterone Acetate” for Therapy
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Acne: a side‐effect of masculinizing hormonal therapy in transgender patients
- Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals
- Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris
- 6 Peripheral androgens and the role of androstanediol glucuronide
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Dihydrotestosterone Stimulates 5a-Reductase Activity in Pubic Skin Fibroblasts*
- Androgens in women
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells
- Hirsutism and the Variable Response of the Pilosebaceous Unit to Androgen
- GC-MS determination of steroids related to androgen biosynthesis in human hair with pentafluorophenyldimethylsilyl–trimethylsilyl derivatisation
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Menopause and aging, quality of life and sexuality
- STEROIDS AND STEROID-LIKE COMPOUNDS
- C<sub>19</sub>and C<sub>21</sub>5<i>β</i>/5<i>α</i>Metabolite Ratios in Subjects Treated with the 5<i>α</i>-Reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5<i>α</i>-Reductase Deficiency*
- 46,XY DSD due to impaired androgen production
- Male androgenetic alopecia
- The biochemical and phenotypic characterization of females homozygous for 5 alpha-reductase-2 deficiency.
- Androgen Conjugates: Physiology and Clinical Significance
- Frontal fibrosing alopecia: demographic and clinical characteristics of 490 cases
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- 8 Hair follicles and associated glands as androgen targets
- Nipple Differentiation in Fetal Male Rats Treated with an Inhibitor of the Enzyme 5<i>α</i>-Reductase: Definition of a Selective Role for Dihydrotestosterone*
- EFFECTS OF A LOW‐DOSE DESOGESTREL‐ETHINYLESTRADIOL COMBINATION ON HIRSUTISM, ANDROGENS AND SEX HORMONE BINDING GLOBULIN IN WOMEN WITH A POLYCYSTIC OVARY SYNDROME
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes